Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Vesair® Bladder Control System for the Treatment of Stress Urinary Incontinence in Post-Menopausal Women

NCT04026347 is registered in ClinicalTrials.gov with Solace Therapeutics, Inc. as lead sponsor.

NCT NCT04026347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04026347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Vesair® Bladder Control System for the Treatment of Stress Urinary Incontinence in Post-Menopausal Women
Lead sponsor
Solace Therapeutics, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
February 1, 2020
Completion date
April 15, 2022
Enrollment
158 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

stress urinary incontinence